Loss of Y and clonal hematopoiesis in blood—two sides of the same coin?

Viktor Ljungström; Jonas Mattisson; Jonatan Halvardson; Tatjana Pandzic; Hanna Davies; Edyta Rychlicka-Buniowska; Marcus Danielsson; Paul Lacaze; Lucia Cavelier; Jan P. Dumanski; Panagiotis Baliakas; Lars A. Forsberg

doi:10.1038/s41375-021-01456-2

Loss of Y and clonal hematopoiesis in blood—two sides of the same coin?

Viktor Ljungström, Jonas Mattisson, Jonatan Halvardson, Tatjana Pandzic, Hanna Davies, Edyta Rychlicka-Buniowska, Marcus Danielsson, Paul Lacaze, Lucia Cavelier, Jan P. Dumanski, Panagiotis Baliakas, Lars A. Forsberg

Research output: Contribution to journal › Letter › Other › peer-review

18 Citations (Scopus)

Original language	English
Pages (from-to)	889-891
Number of pages	3
Journal	Leukemia
Volume	36
Issue number	3
DOIs	https://doi.org/10.1038/s41375-021-01456-2
Publication status	Published - Mar 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41375-021-01456-2Licence: CC BY

Cite this

@article{5802c742d87443569185f4e4a7ec8dd2,

title = "Loss of Y and clonal hematopoiesis in blood—two sides of the same coin?",

author = "Viktor Ljungstr{\"o}m and Jonas Mattisson and Jonatan Halvardson and Tatjana Pandzic and Hanna Davies and Edyta Rychlicka-Buniowska and Marcus Danielsson and Paul Lacaze and Lucia Cavelier and Dumanski, {Jan P.} and Panagiotis Baliakas and Forsberg, {Lars A.}",

note = "Funding Information: This result is part of a project LAF has received funding from the European Research Council (ERC) under the European Union{\textquoteright}s Horizon 2020 research and innovation programme (Grant agreements No. 679744 and 101001789). LAF is also supported by grants from the Swedish Research Council (#2017-03762), the Swedish Cancer Society (# 20-1004) and Kjell och M{\"a}rta Beijers Stiftelse. PB is supported by grants Lion{\textquoteright}s Cancer Research Foundation, Uppsala. JPD is supported by grants from the Hj{\"a}rnfonden, Swedish Cancer Society, the Swedish Research Council, Alzheimerfon-den, Konung Gustav V:s och Drottning Viktorias Frimurarestiftelse, the Science for Life Laboratory, Uppsala and the Foundation for Polish Science under the International Research Agendas Programme. JH is supported by Marcus Borgstr{\"o}ms stiftelse. PL is supported by an Australian National Heart Foundation Future Leader Fellowship (ID 102604). The authors would like to acknowledge Clinical Genomics Uppsala, Science for Life Laboratory, Dept. of Immunology, Genetics and Pathology, Uppsala University, Sweden for providing assistance in sequencing and analysis. Genotyping was performed at SNP&SEQ facilities at Uppsala University and SciLifeLab. SNP&SEQ is part of the National Genomics Infrastructure (NGI) Sweden supported by the Swedish Research Council and the Knut and Alice Wallenberg Foundation. Data handling and computations were enabled by resources provided by the Swedish National Infrastructure for Computing (SNIC) at Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) partially funded by the Swedish Research Council (#2018-05973). Funding Information: JPD and LAF are cofounders and shareholders in Cray Innovation AB. PB has received honoraria from Abbvie, Gilead and Janssen and research funding from Gilead. All other authors declare no competing interest.",

year = "2022",

month = mar,

doi = "10.1038/s41375-021-01456-2",

language = "English",

volume = "36",

pages = "889--891",

journal = "Leukemia",

issn = "0887-6924",